David Meek, new Mirati CEO (Marlene Awaad/Bloomberg via Getty Images)
Fresh off FerGene's meltdown, David Meek takes over at Mirati with lead KRAS drug racing to an approval
In the insular world of biotech, a spectacular failure can sometimes stay on any executive’s record for a long time. But for David Meek, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
